New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Quick Hits: FDA Approves Artificial Pancreas

The Control-IQ artificial pancreas device for people living with Type 1 diabetes was developed at the University of Virginia.

A recent NBC29 article noted the FDA’s approval of a new device that will likely improve the lives of those living with Type 1 Diabetes. Gone are the days of pricing one’s finger to check blood sugar levels and manually injecting insulin thanks to a new artificial pancreas. The device is called Control-IQ, and it’s based on research and technology developed at the University of Virginia. Control-IQ monitors blood glucose levels continuously, and automatically delivers insulin when levels rise.

The FDA’s green light comes after a multicenter clinical trial was published in the New England Journal of Medicine that found the Control-IQ to be more effective than existing treatments for type 1 diabetes.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub